COVID19 News & Analysis

Fresh pandemic fears may stoke demand for these vaccine makers.

But a V-shaped recovery like the one seen in 2021 is very unlikely in 2023.

Morningstar analyst Brian Han believes that growth is on the way for undervalued telco TPG.

More strong hiring in March is good news for the economy.

Businesses exploit the psychological processes that people go through when they decide to buy something, but does the US research work when faced...

Long gone is the time when investing was finding traditional value stocks making profits.

The focus is on Magellan for its investment performance and departure of the CEO, but Douglass says the pandemic, inflation, rising rates and Middle...

Analysts say these 'reopening' stocks still have a way to run as trade roars back.

We don’t expect any changes to our fair value estimates or moat ratings for the mRNA manufacturers.

Surge in delta-variant will only moderately delay the return to normal.